A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40
Goldman et al.
Clinical Infectious Diseases 2005;41:1473-1480.
ABSTRACT
| FULL TEXT
Antifungal Drug Resistance
Loeffler and Stevens
Clinical Infectious Diseases 2003;36:S31-S41.
ABSTRACT
| FULL TEXT
Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial
Pagani et al.
J Antimicrob Chemother 2002;50:231-240.
ABSTRACT
| FULL TEXT
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
Martinez et al.
J Antimicrob Chemother 2002;49:515-524.
ABSTRACT
| FULL TEXT
Rapid Identification of Yeasts in Positive Blood Cultures by a Multiplex PCR Method
Chang et al.
J. Clin. Microbiol. 2001;39:3466-3471.
ABSTRACT
| FULL TEXT
Evolution of Antifungal Susceptibility among Candida Species Isolates Recovered from Human Immunodeficiency Virus--Infected Women Receiving Fluconazole Prophylaxis
Vazquez et al.
Clinical Infectious Diseases 2001;33:1069-1075.
ABSTRACT
| FULL TEXT
Evaluation of Etest for Direct Antifungal Susceptibility Testing of Yeasts in Positive Blood Cultures
Chang et al.
J. Clin. Microbiol. 2001;39:1328-1333.
ABSTRACT
| FULL TEXT
Synergism of Voriconazole and Terbinafine against Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis
Weig and Muller
Antimicrob. Agents Chemother. 2001;45:966-968.
ABSTRACT
| FULL TEXT
The Evolution of Candida Species and Fluconazole Susceptibility among Oral and Vaginal Isolates Recovered from Human Immunodeficiency Virus (HIV)--Seropositive and At-Risk HIV-Seronegative Women
Sobel et al.
The Journal of Infectious Disease 2001;183:286-293.
ABSTRACT
| FULL TEXT
Refractory Mucosal Candidiasis in Advanced Human Immunodeficiency Virus Infection
Fichtenbaum et al.
Clinical Infectious Diseases 2000;30:749-756.
ABSTRACT
| FULL TEXT
A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
Martin-Mazuelos et al.
J Antimicrob Chemother 1999;43:477-481.
ABSTRACT
| FULL TEXT
Thirteen-Year Evolution of Azole Resistance in Yeast Isolates and Prevalence of Resistant Strains Carried by Cancer Patients at a Large Medical Center
Boschman et al.
Antimicrob. Agents Chemother. 1998;42:734-738.
ABSTRACT
| FULL TEXT
Activity of Voriconazole, a New Triazole, Combined with Neutrophils or Monocytes against Candida albicans: Effect of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
Vora et al.
Antimicrob. Agents Chemother. 1998;42:907-910.
ABSTRACT
| FULL TEXT
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White et al.
Clin. Microbiol. Rev. 1998;11:382-402.
ABSTRACT
| FULL TEXT
Fluconazole as Prophylaxis Against Fungal Infection in Patients With Advanced HIV Infection
Manfredi et al.
Arch Intern Med 1997;157:64-69.
ABSTRACT
